Medigen Biotechnology. has filed a patent for an automated cell culture device with a main body enclosing a receiving space and a platform with a sliding track. The device includes a clamping member to prevent fluid flow in a culture bag. GlobalData’s report on Medigen Biotechnology gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Data Insights Medigen Biotechnology Corp - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Medigen Biotechnology, Peptide pharmacophores was a key innovation area identified from patents. Medigen Biotechnology's grant share as of January 2024 was 28%. Grant share is based on the ratio of number of grants to total number of patents.

Automated cell culture device with clamping member for fluid control

Source: United States Patent and Trademark Office (USPTO). Credit: Medigen Biotechnology Corp

The patent application (Publication Number: US20240034982A1) describes an automated cell culture device with innovative features. The device includes a main body with a platform for supporting a culture bag, which has a fluid inlet at one end. A clamping member on a sliding track is designed to prevent fluid from flowing towards the other end of the bag. Additionally, pulling mechanisms at the other end of the platform help in retaining the bag securely.

Furthermore, the device incorporates gripping members with magnetic pieces to hold the sides of the bag, along with a pushing mechanism at one end for lifting and lowering the bag. A unique ventilation member with a bumpy surface is also included to facilitate breathing of the culture bag. Overall, the automated cell culture device offers a comprehensive solution for efficient cell culture processes, with mechanisms for secure clamping, pulling, and ventilation to ensure optimal conditions for cell growth and maintenance.

To know more about GlobalData’s detailed insights on Medigen Biotechnology, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies